程玮璐,王泽华,刘英慧

3D生物打印技术是将生物材料和活细胞在指定的逐层堆叠的组织中同步定位，获得的3D类器官组织具有类似于生理组织，并在一定程度上模仿器官功能的特点，可用于动物实验替代和药物临床模型。本文通过搜集3D打印技术在类器官的应用情况，汇总了3D打印技术在类器官领域的研究进展。目前，3D打印技术主要在类器官芯片及组织器官再生领域有较多应用，但由于技术成熟度和监管风险等问题，尚未广泛应用于产品开发及临床检测。

3D打印技术；类器官；应用进展

[1]朱丽颖,张丹丹,杜宏英等.三维细胞微流控芯片模型的研究现状和在药物毒性评价中的应用进展[J].天津中医药大学学报,2023,42(02):257-263. [2]冯晓莹,孟倩,陈巍等.类器官芯片在医学研究中的应用进展[J].中国生物工程杂志,2022,42(Z1):112-118. [3]罗志明,邓国豪,王祝兵等.3D打印器官芯片研究进展[J].中国生物医学工程学报,2022,41(05):589-601. [4]王晓冰.类器官和器官芯片[J].百科知识,2015(18):25-28. [5]Johnson, B.N.; Lancaster, K.Z.; Hogue, I.B.; Meng, F.; Kong, Y.L.; Enquist, L.W.; McAlpine, M.C. 3D printed nervous system on a chip[J]. Lab Chip, 2016, 16: 1393–1400. [6]罗志明,邓国豪,王祝兵等.3D打印器官芯片研究进展[J].中国生物医学工程学报,2022,41(05):589-601. [7]Bowser, D.A.; Moore, M.J. Biofabrication of neural microphysiological systems using magnetic spheroid bioprinting[J]. Int. Soc. Biofabr. 2020, 12, 015002. [8]Skardal, A.; Murphy, S.V.; Devarasetty, M.; Mead, I.; Kang, H.; Seol, Y.; Zhang, Y.S.; Shin, S.; Zhao, L.; Aleman, J.; et al. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform[J]. Sci. Rep. 2017, 7, 8837. [9]安凡. 3D多元类器官药物筛选芯片的设计、构建及应用[D].大连:大连理工大学,2016. [10]Gao, Q.; Liu, Z.; Lin, Z.; Qiu, J.; Liu, Y.; Liu, A.; Xiang, M.; Chen, B.; Fu, J.; He, Y. 3D Bioprinting of Vessel-like Structures with Multi-level Fluidic Channels. ACS Biomater. Sci. Eng. 2017. [11]张翠芳.药物增材制造技术中关联知识的识别研究[J].中国中医药图书情报杂志,2019,43(05):33-37. [12]Abudupataer, M.; Chen, N.; Yan, S.; Alam, F.; Shi, Y.;Wang, L.; Lai, H.; Li, J.; Zhu, K.;Wang, C. Bioprinting a 3D vascular construct for engineering a vessel-on-a-chip. Biomed. Microdevices 2020, 22, 10. [13]Kolesky, D.B.; Homan, K.A.; Skylar-scott, M.A.; Lewis, J.A. Three-dimensional bioprinting of thick vascularized tissues. Proc. Natl. Acad. Sci. USA 2016, 113, 3179–3184. [14]Bhise, N.S.; Manoharan, V.; Massa, S.; Tamayol, A.; Ghaderi, M.; Miscuglio, M.; Lang, Q.; Zhang, Y.S.; Shin, S.R.; Calzone, G.; et al. A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication 2016, 8, 014101. [15]Lee, H.; Cho, D.W. One-step fabrication of an organ-on-a-chip with spatial heterogeneity using a 3D bioprinting technology. Lab Chip 2016, 16, 2618–2625. [16]王亚清.基于器官芯片技术的3D人脑和肝类器官模型构建及初步应用[D].大连:大连理工大学,2020. [17]Homan, K.A.; Kolesky, D.B.; Skylar-Scott, M.A.; Herrmann, J.; Obuobi, H.; Moisan, A.; Lewis, J.A. Bioprinting of 3D Convoluted Renal Proximal Tubules on Perfusable Chips. Sci. Rep. 2016, 6, 34845. [18]Zhang, Y.S.; Aleman, J.; Arneri, A.et al. Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials 2016, 110, 45–59. [19]张国栋,杨元展,杨春华等.结直肠类器官芯片灌流培养技术研究[J].生命科学仪器,2022,20(03):40-46. [20]Kim,W.; Kim, G. Intestinal Villi Model with Blood Capillaries Fabricated Using Collagen-Based Bioink and Dual-Cell-Printing Process. ACS Appl. Mater. Interfaces 2018, 10, 41185–41196. [21]Xie, M.; Gao, Q.; Fu, J.; Chen, Z.; He, Y. Bioprinting of novel 3D tumor array chip for drug screening. Bio-Design Manuf. 2020, 3,175–188. [22]赵淼,包永睿,王帅等.微流控芯片及其在肿瘤研究中的应用进展[J].中南药学,2022,20(01):129-135. [23]吴思怡,宋启斌.微流控人体器官芯片在癌症研究中的应用进展[J].肿瘤学杂志,2020,26(08):737-741. [24]李潇萌,管若羽,高建军等.类器官在再生医学中的应用[J].中国细胞生物学学报,2021,43(06):1120-1131. [25]李欣达.同轴水凝胶制造技术在神经再生中的应用进展[J].中华脑科疾病与康复杂志(电子版),2021,11(03):180-182. [26]薛瑞丰,汤宁,潘晨燕等.肝脏类器官构建及其对小鼠部分肝切除术后肝再生的作用[J].肝胆胰外科杂志,2020,32(05):290-296. [27]俞灵琦.类器官,让精准医学和再生医学扬帆远行[J].华东科技,2017(12):62-63. [28]M. Colina, P. Serra, J.M. Fernández-Pradas, L. Sevilla, J.L. Morenza, DNA deposition through laser induced forward transfer, Biosens. Bioelectron. 20 (2005) 1638–1642. [29]傅昭仪.科学家利用毛囊类器官实现体外毛发再生[J].人人健康,2022(22):17. [30]左鹤,刘哲,梅倩茹等.干细胞及类器官在特发性肺纤维化修复和再生中的应用[J].药学学报,2021,56(11):2900-2907+3204. [31]郭贝贝,胡慧丽.类器官在发育与再生中的研究进展[J].中国细胞生物学学报,2021,43(06):1111-1119. [32]R. Gaebel, H. Sorg, K. Reimers, P.M. Vogt, S. Schlie, M. Gruene, G. Steinhoff, B.Polchow, S. Stoelting, L. Koch, N. Ma, B. Chichkov, S. Kuhn, Laser printing of skin cells and human stem cells, Tissue Eng. Part C Methods. 16 (2009) 847–854. [33]T. Boland, M. Aho, M. Zile, T. Xu, C. Baicu, Fabrication and characterization of bioengineered cardiac pseudo tissues, Biofabrication. 1 (2009) 035001. [34]H.-W. Kang, S.J. Lee, I.K. Ko, C. Kengla, J.J. Yoo, A. Atala, A 3D bioprinting system to produce human-scale tissue constructs with structural integrity, Nat. Biotechnol. 34 (2016) 312–319. [35]FDA．Drug development tool (DDT)qualification programs [EB/OL].2023-04-06[2023-07-03].https://www.Fda.gov/drugs/development-approval-process-drugs /drug-development-tool-ddt-qualification-programs. [36]FDA.FDA’s predictive toxicology roadmap[EB/OL].2017-12-30 [2023-07-03].https://www.Fda.Gov/science-research/About-science-research-fda/fdas-predictive-toxicology-Roadmap. [37]傅丽霞,张秀莉,庞晓丛,等.类器官和器官芯片在新药评价中的应用及国内外监管现状分析[J].中国临床药理学杂志,2023,39(18):2724-2730. [38]FDA. Innovative science and technology approaches for new drugs (ISTAND) pilot program [EB/OL]. 2020-11-30 [2023-07-03]. https: //www. Fda. gov /drugs /drug-development-tool-ddt-Qualification-programs /innovative-science-and-technology-Approaches-new-drugs-istand- pilot-program. [39]刘建仓.干细胞再生医学运用的民法规制:意旨,解释与适用[J].西北大学学报:哲学社会科学版,2022,52(6):62-70. [40]赵鹏,谢尧雯.科技治理的伦理之维及其法治化路径[J].学术月刊,2022,54(8):14. [41]乐晶晶.类器官应用的伦理问题及治理对策研究[D].厦门:厦门大学,2020. [42]赵赤鸿,苏丹丹,厉春,等.总体国家安全观下合成生物学风险和应对策略研究[J].中国生物工程杂志,2022,42(12):9. [43]侯艳芳.环境权利之刑事立法批判功能的实现[J].政法论丛,2022(03):141-150.

点击下载PDF